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Abstract 
Aim: To identify factors found in the research literature to be associated with smoking 
cessation in pregnancy. 
Methods: Electronic searches of the bibliographic databases of PubMed, EMBASE, 
PsycINFO, Elsevier, Scopus and ISI Web of Science were conducted to April 2017. All 
studies reporting factors associated with smoking cessation or continuing smoking during 
pregnancy were included and systematically reviewed, irrespective of study design. The 
Newcastle Ottawa Quality Assessment Scale was used to assess the study quality. The 
DerSimonian and Laird random effects model was used to conduct meta-analyses, and where 
effect estimates were reported for factors included in at least three studies. 
Results: Fifty-four studies including 505,584 women globally who smoked before 
pregnancy, 15 clinical trials and 40 observational studies, were included in the review and 36 
(65.5%) were considered to be of high quality. This review identified 11 socio-demographic, 
seven socially related, 19 smoking behaviour related, five pregnancy related, six health 
related and six psychological factors that were significantly associated with smoking 
cessation during pregnancy. The most frequently observed significant factors associated with 
cessation were: higher level of education, pooled OR (95% CI): 2.16 (1.80-2.84), higher 
socio-economic status: 1.97 (1.20-3.24), overseas maternal birth: 2.00 (1.40-2.84), Medicaid 
coverage or private insurance: 1.54 (1.29-1.85), living with partner or married: 1.49 (1.38-
1.61), partner/other members of the household do not smoke: 0.42 (0.35-0.50), lower 
heaviness of smoking index score: 0.45 (0.27-0.77, lower baseline cotinine level: 0.78 (0.64-
0.94), low exposure to second hand smoking: 0.45 (0.20-1.02), not consuming alcohol before 
and/or during pregnancy: 2.03 (1.47-2.80), primiparity: 1.85 (1.68-2.05), planned 
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breastfeeding:1.99 (1.94-2.05), perceived adequate pre-natal care: 1.74 (1.38-2.19), no 
depression: 2.65 (1.62-4.30), and low stress during pregnancy: 0.58 (0.44-0.77). 
Conclusion: A wide range of socio-demographics, relationship, social, smoking-related, 
pregnancy-related, health and psychological factors have been found to predict smoking 
cessation in pregnancy. 
 
Key words: Smoking, cessation, pregnancy, predictors, determinants, systematic review, 
meta-analysis, clinical trials, observational studies, interventions. 
 
INTRODUCTION  
Smoking in pregnancy is a serious public health problem and one of the main preventable 
causes of pregnancy-related morbidity and death. Smoking is associated with adverse 
pregnancy and birth outcomes, including miscarriage, stillbirth, prematurity, low birth 
weight, intrauterine growth restriction, congenital abnormalities, and neonatal or sudden 
infant death [1-5]. Smoking also presents immediate risks for the mother, including placental 
abruption [6], as well as the longer-term risks reported for smokers in general [7]. 
In high income countries, the prevalence of smoking in pregnancy is estimated to be 
between 10% and 26% and is decreasing rapidly in many of these countries [8-12]; whereas, 
in low and middle-income countries the prevalence is between 15% and 37% and is not 
declining in some of these countries [13-16]. Smoking cessation during pregnancy improves 
maternal and birth outcomes [17], yet only about 25% of pregnant smokers stop for at least 
part of their pregnancy and half to two thirds of them return to smoking after giving birth 
[18]. Regular sessions of face-to-face behavioural support is the main intervention 
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demonstrated to be effective as an aid to smoking cessation during pregnancy [17], which can 
be enhanced when supplemented with financial incentives [19]. 
To promote successful maternal smoking cessation during pregnancy, clinicians and 
researchers need to identify factors that facilitate or inhibit the quitting process. These factors 
can then be targeted directly, by smoking cessation interventions, or indirectly by promoting 
cessation interventions to subgroups of women who are less likely to succeed at quitting [20, 
21]. For example, this might include women from socially deprived groups, those with higher 
levels of cigarette dependence, and women living with a partner who smokes [22, 23]. 
The most recent systematic review of predictors of smoking cessation during pregnancy was 
conducted in 2010 [23] and it considered 19 studies which identified socio-
demographic/economic, relationship, psychological, pregnancy and health related factors as 
predictors. However, this review was limited to studies in high-income countries published 
between 1997 and 2008, and excluded intervention studies. There have been a large number 
of studies published since this previous review was undertaken. Furthermore, additional 
factors have since been examined as predictors of cessation during pregnancy, such as 
smoking dependence variables (e.g., Fagerström Test for Cigarette Dependence and urges to 
smoke), as well as variables related to pregnancy, such as adequate pre-natal care, planned 
breast feeding and planned pregnancy. Moreover, a meta-analysis has not been previously 
conducted on this topic.  
This comprehensive systematic review was conducted to examine a wide range of factors that 
may be associated with smoking cessation during pregnancy. Further aims include 
conducting meta-analysis for the frequently reported factors and classifying factors associated 
with cessation into sub-categories, including socio-demographic/economic, relationship and 
social activity, smoking, psychological, pregnancy and health related factors, to help 
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clinicians to target interventions towards different sub-groups of the pregnant population or to 
inform the development of interventions. 
METHODS 
This review was conducted according to the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) statement [24].  
Strategies for searching the literature  
We developed a search strategy and conducted the literature searches in the bibliographic 
databases of PubMed, EMBASE, PsycINFO, Elsevier, Scopus and ISI Web of Science. The 
search was designed to capture all studies reporting factors (predictors) associated with 
smoking cessation during pregnancy. The search terms were: [“predictors” or “factors” or 
“determinants” or “characteristics” or “component”] and [“psychological” or “demographic”] 
and [“pregnancy or pregnant”] and [“smoking cessation” or “smoking or smoker”]. Based on 
the combinations of these terms, several searches were conducted in the above-mentioned 
databases. We examined all the studies included in the previous review [23]. There was no 
restriction on language and the search was completed in April 2017.  
Inclusion and exclusion criteria 
Smoking cessation or continued smoking during pregnancy were considered as the analyses 
outcomes. This included bio-chemically validated and non-validated self-reported smoking 
cessation, and covered both planned and spontaneous quit attempts [25], at any time during 
pregnancy. Studies were included which statistically examined the association of smoking 
cessation or continuing smoking during pregnancy with other factors, irrespective of study 
design. If a study was designed to evaluate an intervention, such as Nicotine Replacement 
Therapy, we did not report the intervention as a predictor. We excluded those studies which 
include non-smoking women before pregnancy, women who had stopped smoking prior to 
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pregnancy, studies reporting predictors of postpartum smoking cessation, and qualitative 
studies (i.e., narrative and case reports). Studies identified by search strategies were screened 
for eligibility; initially on the basis of title and abstract, and then reading the full text of the 
remaining studies. One reviewer (M.R.) screened all studies for inclusion with one-third also 
screened independently by another reviewer (M.U.), with 100% agreement. A hand-search of 
the reference lists of included studies was also conducted. Corresponding authors were 
contacted for additional information where necessary. 
Data extraction 
The following data was extracted from each study by M.R. and was verified by M.U: first 
author name, year and location of publication, study aim and design, participant 
characteristics, including age and smoking behaviours, sample size and smoking cessation 
rate, main outcome measure, biochemical validation, whether all smokers made a quit 
attempt, variables examined as predictors, statistical methods used for the analysis, and 
statistically significant predictors reported, and effect estimates for the association (e.g., ORs 
and 95% confidence intervals CI). 
To aid the description, those factors found to be significantly associated with smoking 
cessation were categorised by grouping thematically similar factors across the included 
papers. The categories were decided through reference to categories used in a review by 
Schneider and colleagues [23] and through discussion involving all authors. Potential 
predictors were grouped into the following domains: socio-demographic/economic, 
relationship, smoking/substance misuse, psychological, pregnancy and health related factors. 
They were also categorised according to the nature of association with smoking cessation 
(i.e., increasing or decreasing odds ratio). 
Meta-analyses 
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A large number of factors significantly associated with smoking cessation during pregnancy 
are identified in this review. However, to pool the effect estimates in a way that will yield 
valuable information about the direction and size of effects and to quantify heterogeneity 
among the included studies, we conducted meta-analyses for those factors whose effect 
estimates were available from at least three studies. We extracted the effect estimates (95% 
confidence intervals), reported as odds ratios (OR: majority), relative risk ratios (RR: one 
study [69]) or prevalence ratios (PR: one study [21]). If an effect estimate was not reported, 
an unadjusted OR and 95% confidence interval (95% CI) was estimated from the available 
data. To ensure consistency of the effect estimates for meta-analysis, for some of the studies, 
the effect estimates were transformed such that the appropriate reference category was used 
with smoking cessation as the outcome. For example, for the meta-analysis of older maternal 
age as a categorical predictor, we extracted effect estimate (ORs) for the oldest versus the 
youngest age category. If a study reported an effect estimate for the youngest age category 
versus oldest age category, we transformed the OR (95% CI) by taking the multiplicative 
inverse. Similarly, if a study reported OR (95% CI) for continuing smoking versus quitting, 
we used the multiplicative inverse to compute OR (95% CI) for quitting versus continuing 
smoking. Assuming heterogeneity of effects, we used DerSimonian and Laird [26] random 
effects model for the meta-analyses to compute pooled effect estimates and a heterogeneity 
index I2. The meta-analyses results were reported as pooled OR (95% CI), along with I2 and 
p-values. 
Quality assessment 
The included studies were randomised controlled trials (RCTs) and observational (cohort and 
cross-sectional). To assess study quality, we used the Newcastle Ottawa Quality Assessment 
Scale (NOQAS) developed for cohort studies [27] and the modified version of the (NOQAS) 
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developed for cross-sectional studies [28]. In the modified version of the scale, criteria for the 
“ascertainment of exposure” was not applicable in this review, therefore we used the original 
criteria as given in the NOQAS for cohort studies. For predictors’ analyses, the overall 
sample of the RCT had been used as for observational cohorts; therefore, we assessed the 
quality of RCTs using the cohort studies scale of NOQAS. The maximum possible score of 
NOQAS was 9 and we used a standard cut-off of 7 to identify studies with high quality 
methodology. Studies were included in the review irrespective of their rating of quality. 
Quality assessment was conducted by two independent reviewers (M.R and S.L), who 
discussed any discrepancies until agreement was met.  
 
 
RESULTS  
The initial search returned more than ten thousand hits; on the basis of the title or abstracts 
this was reduced to 91 studies and, after reading the papers, 55 studies (40 observational and 
15 RCTs) were included in this review (see Figure 1). The characteristics of these studies, 
including a summary of the results of the predictors’ analysis, are presented in supplementary 
table S1. 
Characteristics of the included studies 
Design  
Of the 40 observational studies, 19 were cross-sectional [21, 51-53, 55-57, 59, 61-63, 66, 73, 
75, 77, 79- 81, 82] and 21 were cohort studies [44-50, 54, 58, 60, 64, 65, 67-72, 74, 76, 78]. 
Fifteen studies used secondary data from RCTs [29-43].  
Study location 
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Of the observational studies, 12 were from North America (USA=11, Canada=1), 19 were 
European (multinational=2, UK=2, France=1, Denmark=1, Italy=1, Netherland=2, 
Norway=4, Serbia=1 and Spain=5), five were from Asia (Japan=2, Lebanon=1, Taiwan=1 
and Israel=1) and four were from Australasia (Australian=3, New Zealand=1). Twelve of the 
15 RCTs were from the USA, two were from the UK and one from France. 
Participants 
Among the 55 included studies, the combined total number of women who smoked before 
pregnancy was 505,584. All the studies recruited participants who were at least 16 years of 
age and the mean age of the women ranged from 16 to 50 years. Of the seventeen studies 
(31.5%) that reported quit attempts, all or most of the participants made a quit attempt in 
fifteen studies [21, 29, 30, 33, 34, 35, 36, 37, 39, 41, 42, 43, 49, 75, 81], whilst two other 
studies reported quit attempts for only 17% [32] and 30% [80] of the participants. 
Outcome of biochemical validation 
Sixteen studies, three observational [44, 52, 71] and thirteen RCTs [29, 31-37, 39-43], 
reported predictors of biochemically validated smoking abstinence in pregnancy, using 
salivary or urine cotinine and/or expired carbon monoxide (CO) or urine thiocyanate assays. 
Three of the observational studies [52, 62, 63] and two of the RCTs [40, 43] reported 
predictors of spontaneous quitting during pregnancy without biochemical validation.  
Sample size 
Thirty of the observational studies and ten of the RCTs had large sample sizes (>300) to 
detect small-moderate effect sizes. These ranged from N=303 to N=231,143 for observational 
studies and N=316 to N=957 for the RCTs. Ten of the observational studies and five of the 
RCTs had small sample sizes (range N=35 to N=226) [44, 48, 52, 53, 55, 56, 58, 66, 70, 75] 
and (range N=81 to N=289) [30, 33, 35, 36, 40], respectively, which were likely to detect 
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only large effect sizes.  Of the 13 trials with biochemical validation, nine were sufficiently 
powered (range N= 316 to N=957) to detect small-moderate effect sizes for predictors of 
abstinence [29, 31, 32, 34, 37, 39, 41-43]. 
Quality Assessment 
The median Newcastle-Ottawa Quality Assessment Scale [27, 28] score was 7.0 (range 5–9) 
for cohort studies (including RCTs) and 6.6 (range 4–8) for cross-sectional studies (see 
supplementary tables S2 and S3). Of the 55 included studies, 36 (65.5%) were considered to 
be of high quality (cohort: 29, 31, 32, 34, 36. 37, 39, 41, 42, 45-47, 49, 50, 54, 60, 64, 65, 67, 
69, 72, 74, 76, 78; cross-sectional: 21, 51, 57, 61-63, 73, 77, 79-82). Nineteen (34.5%) were 
deemed to be of low quality. The main reasons for lower quality were non-representativeness 
of the underlying population, non-validation of self-reported outcome, low sample size or 
limited adjustment for potential confounders in the statistical analysis. 
Smoking cessation rates 
Smoking cessation rates reported in the 40 observational studies ranged from 4.0% to 76.2% 
and from 4.3% to 66.0% in the RCTs. 
Analyses techniques  
For the majority of the included studies, statistical analyses to assess the associations were 
performed using simple and multiple logistic regression, or mixed effect logistic models, with 
smoking status during pregnancy as the dependent variable and other factors as independent 
variables. However, it is worth mentioning that the outcome definition is very heterogeneous 
(see column 4 in supplementary Table S1). Moreover, four of the RCTs [29, 30, 33, 34] and 
five of the observational studies [53, 56, 59, 66, 75] did not report adjusting for important 
potential confounders such as age, parity, cigarette dependence, or used analyses other than 
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logistic or mixed effect logistic regression. In addition, seven of the RCTs did not report 
adjusting for the effect of intervention [30, 32-34, 38, 40, 43]. 
Predictors of smoking cessation  
Fifty-four factors significantly associated with smoking cessation are presented in Table 1 
and the forest plots are presented in supplementary Figure S1. When we repeated the 
synthesis for studies where most or all participants made a quit attempt, similar factors were 
identified, and in particular there were significantly reported factors of socio-demographics, 
relationship and social activity, smoking behaviour, pregnancy, health status, and 
psychological factors. No meaningful differences of predictors were identified in studies that 
used biochemical validation compared with those that did not.  
In the following sections, the statistically significant factors are classified into sub-groups 
with a narrative description of the findings.  
Socio-demographic factors 
The socio-demographic factors that were significantly associated with higher likelihood of 
smoking cessation during pregnancy include older maternal age [21,37, 54, 64, 68, 67, 74], 
ethnicity - non-white [50] non-Puerto Rican Hispanic [61, 69] and non-aboriginal [74, 67], 
overseas maternal birth [61, 67, 74, 79], higher level of maternal education [21, 31, 32, 34, 
40, 41, 43, 47, 49, 51, 54, 55, 60, 63, 64, 68, 69, 71, 76, 77, 80, 82] or paternal education 
[49], higher income level [21, 48, 67, 82], currently employed women [70], and private 
medicaid insurance [38, 40, 47, 51, 74]. In contrast, other studies found older age [38, 47, 50, 
51, 66, 69, 76, 82] to be associated with a lower likelihood of smoking cessation during 
pregnancy. 
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Relationship and social activity factors 
Women were more likely to quit during pregnancy if they were married or living with a 
partner [43, 51, 54, 64, 65, 69, 71, 77], were housewives [77], and had support from partner 
and/or others [46]. Women were less likely to quit if they had a partner or household member 
who smoked [21, 38, 44, 46, 59, 62, 70, 71, 72, 73,75, 76, 78, 79, 82] or had exposure to 
second-hand/environmental smoking [32, 42, 44, 63, 71], had a poor maternal childhood, 
defined as brought up without father being around or father’s employment status was 
unknown to her, or had a poor current circumstances, which is defined as becoming a mother 
at a younger age and currently not cohabiting [60].  
Smoking or substance use related factors 
Smoking related variables that significantly predicted lower odds of cessation in pregnancy 
included: higher cigarette consumption before pregnancy as a categorical variable [32, 34, 36, 
39, 40, 44, 45, 47,48, 51, 54, 55, 56, 58, 61, 62, 63, 65, 66, 68, 69, 72, 73, 80, 82] and as a 
continuous variable [37, 43, 76], higher baseline cotinine level [31, 41, 42] or expired CO 
level [39], higher Fagerstrom Test of Cigarette Dependence score [39], higher scores for 
Heaviness of Smoking Index [36, 39, 59] or non-Heaviness of Smoking Index [39], higher 
ratings of urges to smoke [39, 59] or withdrawal symptoms [59], if women reported shorter 
time to smoke their first cigarette on awaking [37,36, 38], younger age at the onset of 
smoking [43, 78] and consumption of more coffee during pregnancy [72]. Women were more 
likely to quit if they: had smoked for a shorter duration [42, 48], did not smoke their first 
cigarette within 30 minutes of awaking [37,36, 38], maintaining complete abstinence during 
the initial two weeks of quit attempt in early pregnancy [35], had a pre-pregnancy/prior quit 
attempt [34, 36], interaction of age and duration of smoking (i.e., younger (18-24 years) 
women who smoked for shorter duration (< 10 years)) [81], used marijuana before pregnancy 
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[61], did not drink alcohol before and/or during pregnancy [47, 49, 58, 82], and interaction of 
delayed discounting and smoking rate at baseline (i.e., those who had delayed discounting of 
spontaneous quit and lower smoking rate at baseline) [43].  
Pregnancy related factors 
Pregnancy related factors found to be significantly associated with a higher rate of smoking 
cessation during pregnancy were: primiparity (i.e., women with no previous pregnancy) [33, 
44, 45, 47, 48, 49, 51, 52, 60, 61, 63, 65, 67, 70, 71, 73, 74, 75, 77, 78, 79, 82], perceiving to 
have received adequate prenatal care [48, 67, 69, 73, 74, 80], having planned breast feeding 
[50,58, 69, 82], having had a prior pre-term birth [69], and having had planned pregnancy 
[77, 79].  
Health related factors 
The health related factors that were significantly associated with higher rates of smoking 
cessation were:  severe nausea [44, 70], family history of diabetes [61], use of folic acid [77], 
and had a known higher risk of foetal harm [59]. Women were less likely to quit who had 
short sleep duration [63], and were holders of a community services card (a healthcare 
subsidy for low-income earners) [70].  
Psychological factors 
Finally, the psychological predictors that were reported to be significantly associated with 
lower likelihood of smoking cessation were: higher levels of anxiety [57] or stress [34, 43, 
57, 59, 61], and domestic violence [57]. Women were more likely to quit during pregnancy if 
they had no depression [30, 31, 40, 52], had higher self-efficacy for quitting [32, 37, 42, 53] 
or readiness to quit [52], or held a stronger belief that smoking will harm their baby [43]. 
Meta-analyses results 
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For eighteen of the factors, which have been reported by at least three studies and have effect 
estimates available, meta-analysis were conducted. For all except age, the pooled effect 
estimates were significant statistically. The number of studies included in the meta-analysis, 
direction and sizes of effects (ORs , 95% CI) were as follow: older maternal age (categorical, 
11 studies: 0.96 (0.72-1.28) and (continuous, 4: 0.98 (0.95-1.02)), overseas maternal birth (4: 
2.00 (1.40-2.84)), higher level of maternal education (20: 2.16 (1.80-2.59)), higher income 
level (3: 1.97 (1.20-3.24)), private medicaid insurance (5: 1.54 (1.28-1.85), living with 
partner/married (7: 1.49 (1.38-1.61)), partner or household member smokes (14: 0.42 (0.35-
0.50)), higher exposure to second-hand smoking (3: 0.45 (0.20-1.02)), higher level of  
Heaviness of Smoking Index (3: 0.45 (0.27-0.77)), higher pre-pregnancy cigarette 
consumption (categorical, 20: 0.28 (0.22-0.35) and continuous, 3: 0.57 (0.38-0.85)), higher 
baseline cotinine level (3: 0.78 (0.64-0.94)), pre-pregnancy lower time to first cigarette on 
waking (3: 0.37 (0.23-0.59)), did not drink alcohol before and/or during pregnancy (4: 2.03 
(1.47-2.80)), primiparity (18: 1.85 (1.68-2.05)), women who were perceived to have adequate 
prenatal care (5: 1.74 (1.38-2.19)), planned  breastfeeding (4: 1.99 (1.94-2.05)),  women not 
having depression (3: 2.65 (1.62-4.30)) or  having stresses (3: 0.58 (0.44-0.77)) during 
pregnancy, (Table 1 and Figure 1S). 
Sources of heterogeneity 
In the meta-analyses, the heterogeneity index I2 ranged from 0% to 98.6%; it was very high 
(≥75%) for ten of the factors (e.g., I2 for categorical age is 96.0% and for continuous age is 
88.9%, p<0.001), and moderate (50%≤ I2 <75%) for four factors [96]. For no alcohol use 
before and/or during pregnancy, planned breastfeeding, not having depression or having 
stress during pregnancy, there was no heterogeneity (I2=0%); however, meta-analyses for the 
latter two factors exclude effect estimates from some of the studies (Table 1 and Figure S1). 
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Heterogeneity among the studies may be due to the design (i.e., RCT, observational cohort 
and cross-sectional), the use of different analytical techniques, outcome definition, 
differences in how the predictors (exposure) were measured or analysed in different studies, 
rates of smoking cessation, time of outcome assessment during pregnancy, study follow-up 
period and gestational age at baseline. 
 
DISCUSSION 
We extracted a wide range of factors that are associated with smoking cessation during 
pregnancy from 55 studies including over a half a million women who smoked before 
pregnancy. The observed significant predictors of cessation were: higher socio-economic 
status (i.e., higher level of maternal education, higher income level or private medicaid 
insurance), overseas maternal birth, living with partner or married, lower exposure to passive 
smoking (i.e., partner/other members of the household do not smoke or low exposure to 
second hand smoking), low cigarette dependence(i.e., pre-pregnancy cigarettes consumption, 
lower time to first cigarette on waking, low baseline cotinine or heaviness of smoking index), 
low exposure to second hand smoking, not drinking alcohol before and/or during pregnancy, 
primiparity, perceived adequate pre-natal care, planned breast feeding, good mental health 
during pregnancy(i.e., no depression or stress), and higher levels of self-efficacy for quitting. 
The findings have implications for the design of smoking cessation interventions and for 
public health policy. First, our findings, especially regarding socio-demographic and 
pregnancy related factors, can help identify and prioritise women who are at increased risk of 
failing to quit or relapsing. This might include women who are of lower education, lower 
socio-economic status, multiparous and single. Secondly, some characteristics are likely to 
have a more direct impact on smoking cessation and might be most appropriate for including 
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as intervention components. For example, high cigarette dependence, having a partner who 
smokes and low levels of self-efficacy for quitting, can be targeted, respectively, by 
pharmaceutical interventions [84], behavioural support that attempts to boost self-efficacy 
[90], and couple-focused interventions to help partners to quit [85-87] where probably the 
most work is needed. 
There are also characteristics that are likely to have a less direct impact on cessation, but 
that can still inform interventions. For example, more work is needed on depression focussed 
interventions [83] and interventions providing encouragement and incentives for 
breastfeeding [88, 89]. 
There are some similarities and some difference between the factors associated with 
smoking cessation observed in this review, and those reported for the general population of 
smokers. Factors which are also associated with cessation in the general population include 
higher socio-economic status, low cigarette dependence, and higher levels of self-efficacy 
[91]. Whereas factors reported here, but not found for smokers in general, include marital 
status, no use of alcohol, good mental health, and low exposure to second-hand smoke. Thus, 
while targeting and developing interventions for pregnant smokers there are several 
additional factors, including pregnancy related factors, that needed to be considered. 
Compared with a previous review of the predictors of smoking cessation during pregnancy 
[23], we identified a broader set of predictors and included a larger number of studies based 
on up to date searches using robust review procedures. Also, we included studies from high-
income countries globally and sought to include studies from low-middle income countries 
(LMICs), but identified only two studies from LMICs. Furthermore, a major limitation in 
previous reviews is the lack of included studies using biochemical confirmation of self-
reported smoking cessation and without such validation it is unclear what proportion of 
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participants have falsified their smoking status. In our review, we included 15 studies that 
used data from RCTs, 13 of which used biochemical validation, and three of the 
observational studies also used biochemical validation. A further strength of our review 
compared with previous reviews is that we included a thorough study quality assessment 
using established scales [27, 28]. 
A limitation with the literature reviewed is that the majority of studies are observational, 
used varied definitions for smoking cessation and had varying sample sizes. Some of the 
studies did not specifically seek to identify the predictors of smoking cessation but reported 
them while evaluating the effect of an intervention. A further limitation with the findings is 
that the majority of the studies either did not report whether all participants made a quit 
attempt or reported that only some made an attempt. These studies combined those who 
actively attempted to quit with those who did not. This may have distorted the findings, as a 
review of predictors of smoking behaviour in the general population of smokers identified 
that while many factors predict making a quit attempt, very few factors predict abstinence 
when only including those who actually made a quit attempt [91]. A further limitation was 
the quality of the studies included. On the basis of our quality assessment, 19 (35%) of the 
studies were considered to be of low quality due to low representativeness, low statistical 
power, design, analyses and no adequate follow ups; however, we have highlighted the 
findings separately for the high quality studies. It is worth acknowledging that NOQAS itself 
has known limitations, such as it often does not inform the evidence synthesis process, 
particularly for systematic reviews of non-randomised studies, including sensitivity analysis, 
narrative assessment and restricting the synthesis to studies at a lower risk of bias, which 
have been discussed elsewhere in some detail [93, 94, 95]. However, NOQAS is a widely 
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used tool for quality assessment in systematic reviews and we assessed the quality using 
NOQAS only and did not exclude any studies based on it. 
This is the first study to conduct meta-analysis for a range of predictors of cessation in 
pregnancy. Meta-analysis was conducted only for factors with effect estimates reported by at 
least three studies, and we could not include all estimates as the appropriate data was not 
always available. These analyses yielded important information about the strength of 
association and the amount of heterogeneity between studies. For example, when the effect 
estimates for maternal older age were pooled, no significant effect was observed statistically, 
and there was high heterogeneity in effect estimates among the studies. There was a high 
degree of heterogeneity for many of the factors investigated, and we used a random effects 
model to allow for between study heterogeneity. We have described potential sources of 
heterogeneity including study design, study population, measuring and assessing factors, 
outcome measure, and timing of outcome measure during pregnancy and when there are 
sufficient studies, this could be explored in the future through meta-regression. The pooled 
analysis was weighted by the inverse of variance but we did not use meta-regression, to 
further explore heterogeneity. As such, the aim of this review was to report the ﬁndings 
narratively and for the majority of the factors meta-analysis was not conducted due to being 
reported by less than three studies, hence, the meta-analyses results must be viewed and 
interpreted cautiously. 
This review identified only two studies from LMICs (Serbia and the Lebanon); 
interestingly, the factors associated with smoking cessation in these countries were similar to 
those identified in women from the high-income nations (i.e., higher socio-economic status, 
other members of the household do not smoke, low cigarette dependence, perceived adequate 
pre-natal care). Further work is needed to explore whether the predictors are the same for 
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LMICs versus high income nations, particularly in relation to factors which are likely to be 
distinct in poorer nations, such as provision of health services and education. This issue is 
particularly important due to concerns that smoking among pregnant women in LMICs is 
declining more slowly compared with high income countries. 
Further research is also needed focusing on predictors for which there were not consistent 
findings (e.g., maternal age) or where there were few high quality studies showing significant 
effects (e.g., ethnicity, nicotine dependence, urges to smoke, and psychological variables 
such as readiness to quit). It is not clear why the findings were inconsistent for maternal age, 
although this is likely to be partly due to variation in how the age variable was defined (e.g., 
categorical versus continuous) in the different studies. However, our thorough meta-analysis 
for age concluded that it is not a significant predictor. Research is also required to investigate 
predictors of quit attempts, which are likely to be distinct from the predictors of success of 
those attempts [91]. Finally, as has been done with predictors of post-partum return to 
smoking [92], studies are needed to explore direct and indirect pathways linking predictors 
with smoking cessation during pregnancy, thereby further focussing the priorities for 
intervention development. 
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Figure 1: Flow diagram of eligible studies 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
15 Studies used data 
from RCTs 
 
40 Observational 
55 papers met the inclusion criteria and were 
included.  
Total number of pregnant women=505,584 
  
From the initial search 10,753 titles or 
abstracts were identified and screened for 
retrieval 
21 Cohort studies 
91 full-text articles assessed 
19 Cross-sectional 
studies 
36 papers were excluded as being 
not relevant:   
10 include non-smoking women 
or women who had stopped before 
pregnancy 
3 reported predictors of 
postpartum cessation 
4 did not report specific 
predictors 
8 were qualitative research  
5 reported intervention only 
1 studied predictors of alcohol 
and tobacco use combined 
2 combined data on pregnant and 
non-pregnant smokers  
3 were previous reviews 
  
   
10,662 papers were excluded as 
being not relevant or duplicates 
 
  
This article is protected by copyright. All rights reserved. 
Table 1: Factors significantly associated with smoking cessation during pregnancy 
 
Factors associated with 
cessation  
Study no: extracted effect estimatesa and pooledcodds ratios  
  ORs/RRs (95% CI)b MA: Pooled 
ORc (95% CI), 
(I2, p) 
Socio-demographic and 
economic factors 
  
Older age 38: 0.98 (0.97-0.99),    [21: 1.55 (1.17-2.05),   
54: 2.09 (1.00-4.30),    64: 1.42 (1.28-1.57),    
68: 2.10 (1.10-4.20),    69: 0.75 (0.70-0.79),    
74: 1.89 (1.56-2.27),    47: 0.30 (0.16-0.56),    
50: 0.92 (0.88-0.97),    51: 0.71 (0.62-0.83),    
66: 0.22 (0.07-0.76),    67: 1.19 (1.01-1.41),    
76: 0.96 (0.94-0.98),    82: 0.31 (0.19-0.53)]*, 
[37: 1.11 (1.04-1.17)]*ϯ 
d:  
0.96 (0.72-1.28), 
(96.0%, <0.001) 
e: 
0.98 (0.95-1.02), 
(88.9%, <0.001) 
Ethnicity-non-White 
women 
[50: 2.70 (1.31-5.58)]*  
Ethnicity-non-Puerto Rican 
Hispanic 
[61: 1.54 (1.11-1.88),    69: 2.12 (1.95-2.31)]*  
Ethnicity (Australian-
aboriginal) 
[74: 0.60 (0.50-0.70),    67: 0.54 (0.43-0.66]*  
Overseas maternal birth 
(immigrant) 
[61: 1.73 (1.02-2.94),    67: 2.71 (2.15-3.43),   
79:  2.17 (1.03-4.54),    74: 1.60 (1.44-1.78)]* 
2.00 (1.40-2.84), 
(81.9%, 0.001) 
Non-Urban resident  [74: 0.70 (0.60-0.90)]*  
Higher level of maternal 
education  
[21: 2.69 (1.60-4.53),    34: 4.40 (1.5-12.8),    
41: 1.82 (1.24-2.67),     49: 1.24 (1.07-1.43)]*ϯ 
 
31: 2.43 (1.30-4.54),      40: 1.37 (1.05-1.75),     
43: 4.62 (1.70-12.54),    47: 1.90 (1.40-2.70),       
51: 1.74 (1.44-2.10),      54: 2.73 (1.90-4.00),   
55: 2.50 (1.20-5.50),      60: 1.72 (1.04-2.86),          
63: 1.83 (1.28-2.62),      64: 1.31 (1.23-1.38), 
68: 2.60 (1.30-5.20),      69: 2.29 (2.18-2.40), 
71: 3.20 (1.60-6.50),      76: 1.91 (1.55-2.35),     
77: 3.64 (2.58-5.14),      80: 2.03 (0.99-4.15), 
82: 3.33 (1.67-5.00)]* 
f: 
2.16 (1.80-2.59) 
(93.2%, <0.001) 
 
Higher socioeconomic 
status 
[21: 1.45 (0.96-2.20)]*ϯ, 48: 2.79 (2.51-3.10), 
[67: 1.8 (NR),                  82: 1.67 (1.00-3.33)]* 
1.97 (1.20-3.24), 
(82.3%, 0.004) 
Higher level of partner’s 
education 
[49: 1.10 (1.00-1.20)]*ϯ  
Employed (currently) 70: 2.37 (1.16-4.85)  
Medicaid coverage or 
private insurance 
38: 2.17 (1.15-4.17),      40: 3.57 (1.16-11.11),    
[51: 1.33 (1.18-1.52),     74: 1.61 (1.29-2.01),      
47: 1.60 (1.10-2.30)]* 
1.54 (1.29-1.85), 
(41.5%, 0.145) 
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Relationship and social 
activities 
  
Living with 
partner/married 
[43: 2.45 (1.17-5.09)]ϯ,  [51: 1.32 (1.17-1.48), 
54: 1.84 (1.20-2.80),       64: 1.42 (1.34-1.51)], 
65: 2.63 (1.41-4.76),      69: 1.52 (1.47-1.57), 
77: 1.75 (1.30-2.35)]* 
1.49 (1.38-1.61), 
(60.5%, 0.019) 
House wife [77: 0.70 (0.51-0.96)]*  
Support from partner and 
others 
[46: #]*  
Partner or household 
member smokes 
[21:0.5 (0.44-0.57)]*ϯ,  38: 0.49 (0.26-0.93), 
44: (NR),                       59: 0.20 (0.12-0.32),    
70: 0.35 (0.17-0.70),     71: 0.20 (0.10-0.20), 
[46: 0.37 (0.20-0.69),    62: 0.56 (0.36-0.87), 
72: 0.40 (0.30-0.50),     73: 0.57 (0.38-0.87),  
76: 0.44 (0.37-0.52),     78: 0.55 (0.37-0.83),   
79: 0.46 (0.30-0.70),     82: 0.60 (0.50-0.80)]*, 
[75: 0.17 (0.03-0.68)]ϯ 
0.42 (0.35-0.50), 
(71.9%, <0.001) 
Exposure to second-hand 
/environmental/passive 
smoking 
[42: 0.66 (0.42-1.03)]*ϯ, [63: 0.70 (0.60-0.81), 
32: (NR)]*,                       44: (NR),                    
71: 0.20 (0.10-0.20) 
0.45 (0.20-1.02), 
(95.3%, <0.001) 
Poorer childhood 
circumstances 
[60: 0.70 (0.54-0.91)]*  
Poorer current 
circumstances 
[60: 0.35 (0.23-0.54)]*  
Smoking and related 
factors  
  
Higher Fagerstrom test of 
Higher cigarette 
dependence 
[39: 0.60 (0.45-0.81)]*ϯ  
Higher Heaviness of 
Smoking Index 
[36: 0.59 (0.47-0.74),    39: 0.65 (0.48-0.87)]*ϯ, 
59: 0.21 (0.13-0.35) 
0.45 (0.27-0.77), 
(87.5%,<0.001)  
Higher Non-Heaviness of 
Smoking Index 
[39: 0.65 (0.48-0.88)]*ϯ   
Higher pre-pregnancy 
cigarette consumption 
[34: 0.50 (0.40-0.60),    36: (NR),                      
37: 0.85 (0.83-0.87),     39: (NR)]*ϯ,                  
[43: 0.37 (0.30-0.47)]ϯ, 40: 0.15 (0.06-0.32),   
44: (NR),                       48: (NR),                       
55: 0.83 (0.77-0.91),     56: 0.38 (0.16-0.88),     
58: 0.36 (0.18-0.69),     66: 0.13 (0.05-0.37),     
68: 0.08 (0.04-0.16),    [32: (NR),                        
45: 0.02 (0.01-0.04),     47: 0.23 (0.16-0.34), 
51: 0.27 (0.24-0.30),     54: 0.40 (0.29-0.59),      
61: 0.36 (0.19-0.68),     62: 0.21 (0.13-0.35), 
63: 0.41 (0.33- 0.51),    65: 0.45 (0.31-0.64),                   
69: 0.35 (0.34-0.36),     72: 0.30 (0.20-0.30), 
73: 0.12 (0.05-0.31),     76: 0.57 (0.52-0.63),    
80: 0.43 (0.24-0.74),     82: 0.30 (0.30-0.40)]* 
d:  
0.28 (0.22-0.35), 
(96.5%, <0.001) 
e:  
0.57 (0.38-0.85), 
(98.2%, <0.001) 
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Higher baseline cotinine 
level 
[31: 0.92 (0.88-0.95)]*, [41: 0.96 (0.92-0.99), 
42: 0.09 (0.05-0.17)]*ϯ                   
0.78 (0.64-0.94), 
(96.6%, <0.001) 
Higher baseline carbon 
monoxide level 
[39: 0.55 (0.37-0.80)]*ϯ  
Higher Urges/craving to 
smoke 
[39: 0.69 (0.51-0.93)]*ϯ,  59: 0.27 (0.15-0.49)  
Higher sensation of 
withdrawal 
59: 0.27 (0.17-0.44)  
Shorter duration (years) of 
smoking 
[42: 2.79 (1.61-4.82)]*ϯ,  48: (NR)  
Pre-pregnancy, lower time 
to first cigarette on waking  
[37:0.51 (0.34-0.76),   36: 0.26 (0.11-0.65)]*ϯ, 
38: 0.28 (0.15-0.55) 
0.37 (0.23-0.59), 
(42.2%, 0.177) 
 
Smoking status in the first 
two weeks following the 
quit attempt. 
[35: 30.4 (6.0-154.6)]ϯ  
Pre-pregnancy/prior 
attempt to quit 
[34: 2.30 (1.10-4.50),  36: 3.55 (1.65-7.63)]*ϯ  
Attempts to quit during 
pregnancy 
[36: 1.18 (1.00-1.38)]*ϯ  
Interaction of age and 
number of years smoked 
[81: 2.83 (1.44-5.58)]*ϯ  
Age at onset of smoking [43: 1.15 (1.04-1.28)]ϯ, [78: 1.16 (1.08-1.25)]*  
Daily  use of pre-
pregnancy marijuana 
[61: 0.54 (0.31-0.87)]*  
No alcohol use before 
and/or during pregnancy 
[47: 2.10 (1.00-4.10),    58: 2.58 (1.00-6.66),   
82: 2.00 (1.11-3.33)]*, [49: 1.86 (1.07-3.24)]*ϯ 
2.03 (1.47-2.80), 
(0.0%, 0.950) 
 
Interaction of delayed 
discounting of spontaneous 
quit  and smoking rate 
[43: 0.74 (0.61-0.90)]ϯ  
Coffee consumption during 
pregnancy 
[72: 0.20 (0.20-0.30)]*  
Pregnancy related factors   
Primiparity [33:(NR),                       75: 3.92 (1.78-8.99)]ϯ, 
44: (NR),                       48: 2.19 (NR),             
52: 1.48 (1.09-2.01),     70: 5.05 (1.90-13.27), 
71: 1.67 (1.11-2.00),    [49: 2.00 (1.15-3.45)]*ϯ, 
[45: 2.04 (1.16-3.57),    47: 1.90 (1.40-2.50), 
51: 1.88 (1.69-2.10),     60: 2.29 (1.92-2.72), 
61: 2.78 (1.54-5.00),     63: 2.17 (1.85-2.50), 
65: 1.64 (1.04-2.57),     67: 1.68 (1.62-1.73),   
73: 1.49 (1.03-2.17),     74: 2.22 (2.04-2.44), 
77: 1.24 (1.03-1.49),     78: 1.59 (1.06-2.38), 
79: 1.54 (1.17-2.03),     82: 1.67 (1.25-2.00)]* 
g:  
1.85 (1.68-2.05), 
(78.4%, <0.001) 
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Women who were 
perceived to have adequate 
prenatal care 
48: (NR),                     [67: 2.33 (1.91-2.85), 
69: 1.67 (1.56-1.75),    73: 2.72 (1.3-5.68),    
74: 1.27 (1.18-1.37),    80: 1.72 (1.02-2.91)]* 
1.74 (1.38-2.19), 
(92.3%, <0.001) 
Planned breastfeeding 58: 3.70 (1.60-8.80),   [50: 1.73 (1.01-2.98),    
69: 1.99 (1.94-2.05),    82: 2.00 (1.67-2.50)]* 
1.99 (1.94-2.05), 
(0.0%, 0.514) 
Prior preterm birth [69: 0.82 (0.76-0.88)]*  
Planned  pregnancy [77: 1.31 (1.00-1.72),   79: (NR)]*   
Health Related factors   
Severe nausea 44: (NR),                    70: 2.59 (1.11-6.04)  
Community services card 
holders 
70: 0.41 (0.19-0.86)  
Known higher risk of   
foetal harm 
59: 3.67 (1.73-7.78)  
Short sleep duration [63: 0.62 (0.51-0.75)]*  
Use of folic acid [77: 1.59 (1.22-2.06)]*  
Psychological factors    
No depression  [30: 6.28 (0.76-52.17)]ϯ,  
[31: 2.69 (1.27-5.68)]*,   40: 2.39 (1.22-4.70),    
52: 1.09 (1.01-1.17) 
h:  
2.65 (1.62-4.30), 
(0.0%, 0.694) 
        
Per unit increase in anxiety 
score 
[57: 0.99 (0.98-1.00)]*  
Stress during pregnancy [34:0.80 (0.70-0.90)]*ϯ, [43: 0.86 (0.76-0.97)]ϯ,  
[57: 0.57 (0.35-0.94),     61: 0.64 (0.38-1.06)]*, 
59: 0.54 (0.34-0.85), 
i:  
0.58 (0.44-0.77), 
(0.0%, 0.887) 
Perception of harm to baby 
due to smoking 
[43: 14.42 (1.77-117.25)]ϯ,    
Higher self-
efficacy/confidence for 
quitting 
[42: 3.59 (2.29-5.65),   37: 0.84 (0.76-0.93)]*ϯ, 
[32:(NR)]*                    53: (NR),        
 
Higher readiness for 
quitting 
[52: 1.05 (1.02-1.08)]  
Domestic violence,   [57: 0.31 (0.12-0.84)]*  
a: Effect estimates extracted are odds ratios (OR: adjusted majority), relative risk ratios (RR: 
one study [69]) or prevalence ratio (PR: one study [21]). If an effect estimate was not 
reported, an unadjusted OR and 95% confidence interval (95% CI) was estimated from the 
available data. 
b: The effect estimate (e.g., OR) shows the direction of association; a factor is said to be 
associated with an increase likelihood of smoking cessation if OR>1 and decrease likelihood 
if OR<1. To ensure consistency of the effect estimates for meta-analysis, for some of the 
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studies, the effect estimates are transformed to represent smoking cessation outcome and/or 
(appropriate category versus reference) of the predictor.  
c: Using DerSimonian and Laird random effects model for meta-analysis, the effect estimates 
were combined to compute a pooled OR for the association. 
p: Represents the p-values for testing the hypothesis that the studies are homogeneous.  
d: The predictor (factor) is assessed as a categorical variable. 
e: The predictor is assessed as a continuous variable. 
f: Excluded [40] from meta-analysis as it reported OR (95% CI) for continuous age (years) of 
education. 
g: Excluded [52] from meta-analysis as it reported OR (95% CI) for continuous number of 
children. 
h: Excluded [52] from meta-analysis as it reported OR (95% CI) for continuous score of the 
depression scale. 
i: Excluded two studies [34 and 43], as they reported OR (95% CI) for continuous score of 
the stress scale.  
*: Studies methodology is classed as of high quality by the NOQAS (i.e., score of 7 and 
above). 
ϯ: Study(ies) with all or most of the participants made a quit attempt. 
*ϯ: Studies enclosed are fulfilling both of the above two criteria (* and ϯ. 
#: The OR (95% CI) interpretation is wrong in the original study, therefore it was not 
reported. 
(NR): Effect estimate and/or 95% CI are not reported and can not be estimated from the 
available results published in the study. 
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I2: I-square is the measure (index) of heterogeneity among the studies included in the meta-
analysis. More than 75% can be considered as high heterogeneity, more than 50% moderate, 
and 25% as low heterogeneity [96]. 
p: Represents the p-values for testing the hypothesis that the studies are homogeneous. 
 
